What Is Evidence-Based Sexual Wellness Care?
Evidence-based sexual wellness care matches licensed medical, pelvic, and counseling options to the symptom. Hormones and devices are not automatic first steps.
Overview
Evidence-based sexual wellness care is a confidential clinical evaluation that names a specific concern—desire, arousal, erection, orgasm, pain, vaginal dryness, or urinary symptoms—then matches licensed treatments to that concern. It is not a hormone subscription, a PRP brand name, or a device package sold as rejuvenation. Sexual health includes physical, emotional, relational, and safety factors. ACOG describes female sexual dysfunction as distress in desire, arousal, orgasm, or pain and recommends a biopsychosocial approach. AUA treats erectile dysfunction as a medical symptom and a cardiovascular risk marker. NAMS frames genitourinary syndrome of menopause as a treatable set of tissue and sexual symptoms, starting with moisturizers and lubricants and using local hormones when needed.
A responsible visit is led by a physician, nurse practitioner, or physician assistant who can examine, order indicated tests, and prescribe. Licensed pelvic floor physical therapists and licensed sex therapists are part of care when muscle pain or psychological distress is present. Health coaching and med-spa technical staff are not substitutes for that team. The history should cover onset, medicines, cardiometabolic risk, menopause or androgen-deprivation history, pelvic surgery, mood, trauma, consent, and intimate-partner safety. Broad “optimization” labs are not automatically required.
First-line options, when indicated, include treating underlying disease, FDA-approved PDE5 inhibitors for ED, vacuum devices, local vaginal therapies for GSM, pelvic floor PT, and qualified sexual counseling. Hormones require a diagnosed indication and monitoring. PRP injections marketed as O-Shot or P-Shot, low-intensity shockwave as routine ED care, and vaginal energy devices as proven GSM therapy have important evidence and regulatory limits. The FDA has warned about serious harms from unapproved energy-based “vaginal rejuvenation.” Those services should be disclosed as limited or investigational, not as the definition of sexual wellness.
Urgent problems—sexual assault, suicidal crisis, genital injury, priapism lasting four hours, severe pelvic or testicular pain, or heavy bleeding—belong in emergency or specialty care, not a membership consult. Reasonable goals are less distress and a documented plan, not guaranteed performance or a cosmetic result.
- Ask which guideline the plan follows for your exact symptom.
- Decline a package that skips exam, heart-risk questions, or licensed counseling when those are indicated.
Benefits
Names the actual symptom instead of selling a generic “optimization” protocol
Uses licensed medical, pelvic-PT, and sex-therapy options with stronger evidence first
Screens cardiovascular, infection, bleeding, trauma, and safety issues that change the plan
States when hormones, PRP, shockwave, or energy devices are off-label or weakly supported
Defines follow-up and stop rules rather than an open-ended membership
The Procedure
1
Confidential history and safety screen
2
Targeted examination and tests
3
Match first-line options to the symptom
4
Disclose weak or unapproved offerings
5
Document follow-up
Preparation
Bring every medicine and supplement, oncology or hormone records, and a plain-language list of what changed and when. Decide whether you want a partner present; you can still ask for private time. Testing is individualized. Do not stop cardiac medicines to “prepare” for a sexual-function visit. If you are unsafe at home, book a confidential individual appointment.
Recovery & Aftercare
History, exam, counseling, pelvic PT, and most prescriptions have no downtime. Injections, energy devices, and procedures—if you still choose them after counseling—have separate aftercare and are not required for an evidence-based plan. Report priapism, chest pain, heavy bleeding, or a severe reaction immediately rather than waiting for a wellness follow-up.
Risks & Considerations
Harms include missed cardiovascular disease, infection, or cancer warning signs; nitrate–PDE5 interactions; unsupervised hormones; and burns or pain from unapproved energy devices. Privacy failures and coercive sales are clinic-quality problems. Coaching or cash-pay injections sold as first-line care can delay licensed therapy and guideline-directed treatment. Emergency symptoms should not wait for a membership slot. A partner present without private screening can hide intimate-partner violence.
Frequently Asked Questions
References
[1]
ACOG Practice Bulletin 213: Female Sexual Dysfunction
https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2019/07/female-sexual-dysfunction[2]
AUA: Erectile Dysfunction Guideline
https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline[3]
The Menopause Society: Genitourinary Syndrome of Menopause
https://menopause.org/patient-education/menopause-topics/genitourinary-syndrome-of-menopause[4]
FDA: Warning on energy-based vaginal rejuvenation devices
https://www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic-procedures-fda-safety-communication[5]
NIDDK: Erectile Dysfunction
Your Privacy Choices